Single-Port Robotic Lobectomy for Early-Stage NSCLC
Official title: Surgical Outcome Of da Vinci Single-port Surgical System In Lung Cancer
Run by European Institute of Oncology · NCT07790406 · Data updated 2026-11-12
This study tests the safety and outcomes of using the da Vinci Single-Port system for lobectomy and lymph node dissection in people with early-stage non-small cell lung cancer.
Quick facts
| Study type | Observational |
|---|---|
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | European Institute of Oncology Academic / other |
| Locations | 1 site (Milan, Mi) |
| Status | Recruiting |
| Started | February 2, 2026 |
| Main results expected | March 2032 |
| Study ends | December 2032 |
| Registry record updated | August 27, 2026 |
| Trial ID | NCT07790406 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with proven NSCLC stage I who have undergone or will undergo lobectomy with radical lymph node dissection using the single-port robotic system and have given consent.
✕Probably not a fit
Patients not expected to benefit are those with non-NSCLC, advanced stage disease, or those who do not undergo the single-port lobectomy procedure.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is an observational, monocentric data collection project conducted at the European Institute of Oncology in Milan. It includes prospective and retrospective data from patients treated with the single-port robotic approach for lobectomy and radical lymph node dissection, following standard guidelines. The study aims to describe surgical feasibility, perioperative results, oncological adequacy, and postoperative recovery while ensuring coded data privacy and non-profit governance. It does not randomize patients or compare directly with other techniques, but may inform future comparisons and best practices. Participation is limited to patients with proven NSCLC stage I who underwent, or will undergo, the specified operation with consent.
Why it matters
Potential benefit: If successful, the study could clarify the safety and practicality of single-port robotic surgery for early NSCLC and help guide future clinical decisions.
How similar studies have gone: Robotic single-port approaches have shown promise in early reports, but related evidence remains limited and ongoing.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * all patients with proven non-small cell lung cancer (NSCLC) clinical stage I (9th TNM edition), who have undergone or will undergo lobectomy plus radical lymph node dissection following the STS guide line Exclusion Criteria: * no consent
Where it's running
-
Istituto Europeo di Oncologia
Milan, Mi, Italy Recruiting
Study contacts
- Study coordinator: Monica Casiraghi, MD PhD
- Email: monica.casiraghi@ieo.it
- Phone: 025748662
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Integrated genomic and clinical database for cancer biomarker discovery
Researchers are building a combined genomic and clinical database at Samsung Medical Center to test biomarkers for cancer diagnosis, treatment choice, and predicting how well treatments work.
-
Understanding what patients want from NSCLC treatment monitoring
Researchers are testing how patients with non-small cell lung cancer feel about and prefer monitoring their symptoms during treatment, with input from patients, caregivers, and clinicians.
-
PD-L1-targeted PET probe to map PD-L1 in solid tumors
A PET tracer called 18F-F-PDL1-3 is being tested to see if it can detect PD-L1 expression in primary and metastatic tumors to help guide personalized treatment.
-
Cardiorespiratory fitness after lobectomy versus sublobar resection in NSCLC
This study tests how different lung surgeries (lobectomy vs. sublobar resection) affect fitness levels after surgery in people with non-small cell lung cancer.
-
CAIX-targeted PET/CT imaging in solid tumors
Researchers are testing a CAIX-targeted PET/CT imaging agent to see if it detects and reflects CAIX levels in solid tumors like clear cell renal cell carcinoma, NSCLC, and breast cancer.
-
NUT Project: Nutritional Support in Thoracic Cancer
We’ll see if providing tailored nutrition guidance and assessment helps people with advanced lung cancer during their treatment.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.